Literature DB >> 32890864

The history of multiple adverse childhood experiences in patients with schizophrenia is associated with more severe symptomatology and suicidal behavior with gender-specific characteristics.

Cintia R Prokopez1, Miguel Vallejos2, Romina Farinola2, Germán Alberio3, Gabriela B Caporusso4, Linda G Cozzarin4, Luciana C Chiapella5, Pamela Fuentes3, Federico M Daray6.   

Abstract

The current study aims to compare the prevalence of adverse childhood experiences (ACEs) between patients with schizophrenia and non-psychiatric control group, and to analyze the association of having suffered multiple ACEs with clinical symptoms of schizophrenia and suicidal behavior. A multicenter, cross-sectional study was conducted across three facilities in Buenos Aires, Argentina. One-hundred patients with schizophrenia and 50 healthy subjects were assessed with the Adverse Childhood Experiences questionnaire (ACE-Q), the Positive and Negative Syndrome Scale (PANSS), and the Columbia-Suicide Severity Rating Scale (C-SSRS). We observed that the prevalence of at least one ACE in schizophrenic patients was almost double in comparison with the non-psychiatric control group. Multiple ACEs were associated with persistent auditory hallucinations and lower negative symptoms in both sexes. Higher frequency of death ideation and a higher number of suicide attempts were reported among women. The strength of this study is the possibility of comparing the presence of ACEs between schizophrenic patients and non-psychiatric control using the same questionnaire in an under-reported sample of low socio-economic patients assisted in public hospitals. A limitation is that the history of ACEs relied on the retrospective assessment of childhood experiences, and adults could over-report ACEs because of recall bias.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adverse childhood experiences; Adverse childhood experiences questionnaire; Hallucinations; Schizophrenia; Suicidal behavior

Mesh:

Year:  2020        PMID: 32890864     DOI: 10.1016/j.psychres.2020.113411

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Association between Childhood Maltreatment and Suicidal Ideation: A Path Analysis Study.

Authors:  Isabella Berardelli; Salvatore Sarubbi; Elena Rogante; Denise Erbuto; Carlotta Giuliani; Dorian A Lamis; Marco Innamorati; Maurizio Pompili
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

2.  Association of positive and adverse childhood experiences with risky behaviours and mental health indicators among Chinese university students in Hong Kong: an exploratory study.

Authors:  Zijun Xu; Dexing Zhang; Hanyue Ding; Xiaoxiang Zheng; Rym Chung-Man Lee; Zuyao Yang; Phoenix Kit-Han Mo; Eric Kam-Pui Lee; Samuel Yeung-Shan Wong
Journal:  Eur J Psychotraumatol       Date:  2022-05-25

Review 3.  The Importance of Suicide Risk Formulation in Schizophrenia.

Authors:  Isabella Berardelli; Elena Rogante; Salvatore Sarubbi; Denise Erbuto; David Lester; Maurizio Pompili
Journal:  Front Psychiatry       Date:  2021-12-16       Impact factor: 4.157

Review 4.  Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys.

Authors:  W Bai; Z H Liu; Y Y Jiang; Q E Zhang; W W Rao; T Cheung; B J Hall; Y T Xiang
Journal:  Transl Psychiatry       Date:  2021-10-29       Impact factor: 6.222

5.  The Impact of ACEs on BMI: An Investigation of the Genotype-Environment Effects of BMI.

Authors:  Karen A Schlauch; Robert W Read; Iva Neveux; Bruce Lipp; Anthony Slonim; Joseph J Grzymski
Journal:  Front Genet       Date:  2022-03-07       Impact factor: 4.599

6.  Sex-Specific Changes in Choroid Vasculature Among Patients with Schizophrenia and Bipolar Disorder.

Authors:  Chloe Y Li; Itika Garg; Paulo Lizano; John B Miller; Deepthi Bannai; Megan Kasetty; Raviv Katz; Iniya Adhan; Konstantinos A A Douglas; Jay C Wang; Leo A Kim; Matcheri Keshavan
Journal:  Clin Ophthalmol       Date:  2022-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.